929 related articles for article (PubMed ID: 34482117)
21. COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma.
Yang M; Wu X; Hu J; Wang Y; Wang Y; Zhang L; Huang W; Wang X; Li N; Liao L; Chen M; Xiao N; Dai Y; Liang H; Huang W; Yuan L; Pan H; Li L; Chen L; Liu L; Liang L; Guan J
J Hepatol; 2022 May; 76(5):1138-1150. PubMed ID: 35101526
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of lung adenocarcinoma by combinations of sulfasalazine (SAS) and disulfiram-copper (DSF-Cu) in cell line models and mice.
Bagherpoor AJ; Shameem M; Luo X; Seelig D; Kassie F
Carcinogenesis; 2023 Jun; 44(4):291-303. PubMed ID: 37053033
[TBL] [Abstract][Full Text] [Related]
23. SLC27A5 deficiency activates NRF2/TXNRD1 pathway by increased lipid peroxidation in HCC.
Gao Q; Zhang G; Zheng Y; Yang Y; Chen C; Xia J; Liang L; Lei C; Hu Y; Cai X; Zhang W; Tang H; Chen Y; Huang A; Wang K; Tang N
Cell Death Differ; 2020 Mar; 27(3):1086-1104. PubMed ID: 31367013
[TBL] [Abstract][Full Text] [Related]
24. Combination of Metformin and Sorafenib Induces Ferroptosis of Hepatocellular Carcinoma Through p62-Keap1-Nrf2 Pathway.
Tang K; Chen Q; Liu Y; Wang L; Lu W
J Cancer; 2022; 13(11):3234-3243. PubMed ID: 36118519
[TBL] [Abstract][Full Text] [Related]
25. APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy.
Du Y; Zhou Y; Yan X; Pan F; He L; Guo Z; Hu Z
Cell Death Differ; 2024 Apr; 31(4):431-446. PubMed ID: 38418695
[TBL] [Abstract][Full Text] [Related]
26. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.
Shi L; Wu L; Chen Z; Yang J; Chen X; Yu F; Zheng F; Lin X
Cell Physiol Biochem; 2015; 35(6):2333-48. PubMed ID: 25896253
[TBL] [Abstract][Full Text] [Related]
27. Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells.
Bai T; Lei P; Zhou H; Liang R; Zhu R; Wang W; Zhou L; Sun Y
J Cell Mol Med; 2019 Nov; 23(11):7349-7359. PubMed ID: 31507082
[TBL] [Abstract][Full Text] [Related]
28. CRISPR-Cas9-based genome-wide screening identified novel targets for treating sorafenib-resistant hepatocellular carcinoma: a cross-talk between FGF21 and the NRF2 pathway.
Chen J; Jiang S; Shao H; Li B; Ji T; Staiculescu D; He J; Zhao J; Cai L; Liang X; Xu J; Cai X
Sci China Life Sci; 2022 Oct; 65(10):1998-2016. PubMed ID: 35380342
[TBL] [Abstract][Full Text] [Related]
29. CPLX2 Regulates Ferroptosis and Apoptosis Through NRF2 Pathway in Human Hepatocellular Carcinoma Cells.
Li H; Zhao J; Zhong XL; Xu PY; Du LJ; Fang P; Tan LJ; Li MJ; Zhang CF; Cao TS
Appl Biochem Biotechnol; 2023 Jan; 195(1):597-609. PubMed ID: 36107387
[TBL] [Abstract][Full Text] [Related]
30. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
31. Accumulation of phosphorylated p62 is associated with NF-E2-related factor 2 activation in hepatocellular carcinoma.
Shimizu T; Inoue K; Hachiya H; Shibuya N; Aoki T; Kubota K
J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):467-71. PubMed ID: 27246794
[TBL] [Abstract][Full Text] [Related]
32. Disulfiram/Copper Induces Antitumor Activity against Both Nasopharyngeal Cancer Cells and Cancer-Associated Fibroblasts through ROS/MAPK and Ferroptosis Pathways.
Li Y; Chen F; Chen J; Chan S; He Y; Liu W; Zhang G
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31935835
[TBL] [Abstract][Full Text] [Related]
33. Molecular Mechanisms Underlying Hepatocellular Carcinoma Induction by Aberrant NRF2 Activation-Mediated Transcription Networks: Interaction of NRF2-KEAP1 Controls the Fate of Hepatocarcinogenesis.
Haque E; Karim MR; Salam Teeli A; Śmiech M; Leszczynski P; Winiarczyk D; Parvanov ED; Atanasov AG; Taniguchi H
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751080
[TBL] [Abstract][Full Text] [Related]
34. Disulfiram/Copper Induces Immunogenic Cell Death and Enhances CD47 Blockade in Hepatocellular Carcinoma.
Gao X; Huang H; Pan C; Mei Z; Yin S; Zhou L; Zheng S
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230638
[TBL] [Abstract][Full Text] [Related]
35. Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activation.
Sun J; Zhou C; Zhao Y; Zhang X; Chen W; Zhou Q; Hu B; Gao D; Raatz L; Wang Z; Nelson PJ; Jiang Y; Ren N; Bruns CJ; Zhou H
Redox Biol; 2021 May; 41():101942. PubMed ID: 33770521
[TBL] [Abstract][Full Text] [Related]
36. Disulfiram/copper shows potent cytotoxic effects on myelodysplastic syndromes via inducing Bip-mediated apoptosis and suppressing autophagy.
Zha J; Bi S; Deng M; Chen K; Shi P; Feng L; He J; Pu X; Guo C; Zhao H; Li Z; Jiang Y; Song H; Xu B
Eur J Pharmacol; 2021 Jul; 902():174107. PubMed ID: 33865831
[TBL] [Abstract][Full Text] [Related]
37. Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor-4 inhibition in hepatocellular carcinoma.
Iseda N; Itoh S; Toshida K; Tomiyama T; Morinaga A; Shimokawa M; Shimagaki T; Wang H; Kurihara T; Toshima T; Nagao Y; Harada N; Yoshizumi T; Mori M
Cancer Sci; 2022 Jul; 113(7):2272-2287. PubMed ID: 35466502
[TBL] [Abstract][Full Text] [Related]
38. Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents.
Kannappan V; Ali M; Small B; Rajendran G; Elzhenni S; Taj H; Wang W; Dou QP
Front Mol Biosci; 2021; 8():741316. PubMed ID: 34604310
[TBL] [Abstract][Full Text] [Related]
39. CRISPR screens uncover protective effect of PSTK as a regulator of chemotherapy-induced ferroptosis in hepatocellular carcinoma.
Chen Y; Li L; Lan J; Cui Y; Rao X; Zhao J; Xing T; Ju G; Song G; Lou J; Liang J
Mol Cancer; 2022 Jan; 21(1):11. PubMed ID: 34983546
[TBL] [Abstract][Full Text] [Related]
40. Branched-chain amino acid aminotransferase 2 regulates ferroptotic cell death in cancer cells.
Wang K; Zhang Z; Tsai HI; Liu Y; Gao J; Wang M; Song L; Cao X; Xu Z; Chen H; Gong A; Wang D; Cheng F; Zhu H
Cell Death Differ; 2021 Apr; 28(4):1222-1236. PubMed ID: 33097833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
